Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Amortization (2022 - 2024)

Indivior Pharmaceuticals has reported Amortization over the past 3 years, most recently at -$946.0 million for Q4 2024.

  • For Q4 2024, Amortization rose 27.57% year-over-year to -$946.0 million; the TTM value through Dec 2024 reached -$946.0 million, up 27.57%, while the annual FY2024 figure was -$946.0 million, 27.57% up from the prior year.
  • Amortization for Q4 2024 was -$946.0 million at Indivior Pharmaceuticals, up from -$962.0 million in the prior quarter.
  • Over five years, Amortization peaked at $1.3 billion in Q4 2022 and troughed at -$1.3 billion in Q4 2023.
  • A 3-year average of -$496.6 million and a median of -$954.0 million in 2024 define the central range for Amortization.
  • Biggest five-year swings in Amortization: crashed 203.73% in 2023 and later increased 27.57% in 2024.
  • Year by year, Amortization stood at $1.3 billion in 2022, then crashed by 203.73% to -$1.3 billion in 2023, then increased by 27.57% to -$946.0 million in 2024.
  • Business Quant data shows Amortization for INDV at -$946.0 million in Q4 2024, -$962.0 million in Q3 2024, and -$1.0 billion in Q2 2024.